Stammdaten
Unternehmen & Branche
| Name | Parabilis Medicines, Inc. |
|---|---|
| Ticker | PBLS |
| CIK | 0001657677 |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance »
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | SEBULSKY ALAN | Director | Open Market Purchase | 4.065 | 27,10 | 110.146,46 | +0,2% | |
| 2026-06-15 | SEBULSKY ALAN | Director | Open Market Purchase | 5.000 | 26,00 | 129.989,00 | +0,2% | |
| 2026-06-12 | SEBULSKY ALAN | Director | Open Market Purchase | 8.435 | 27,67 | 233.393,08 | +0,3% | |
| 2026-06-11 | SEBULSKY ALAN | Director | Open Market Purchase | 12.500 | 20,00 | 250.000,00 | +0,4% | |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 1.460.397 | 20,00 | 29.207.940,00 | +41,3% | |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 19.728.353 | 20,00 | 394.567.060,00 | +557,7% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
Keine Fondsdaten für dieses Unternehmen vorhanden.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ visuell |
|---|---|---|---|---|---|---|---|
| 18.06.2026 | RA Capital Healthcare Fund, L.P. | Aktivist (13D) | 21,60 % | 26.285.093 | Neu | The Reporting Persons acquired the voting common stock reported herein for investment pu… | |
| 18.06.2026 | RA Capital Management, L.P. (+2) | Aktivist (13D) | 23,80 % | 28.933.371 | Neu | The Reporting Persons acquired the voting common stock reported herein for investment pu… |